The Recall Desk

FDA (Drugs) recall action 81002

Pharm D Solutions, LLC recalled 79 products on 2018-11-07

The FDA (Drugs) publishes a recall like this one as 79 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 79 pages.

Products
79
Announced
2018-11-07
Critical
0
Units
97,103

Why these products were recalled

Lack of Assurance of Sterility

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

51–75 of 79

  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Epi-Shugarcaine Kit Due to Sterility Concerns

    Pharm D Solutions is recalling 70 bottles of Epi-Shugarcaine Kit Solution because the company cannot ensure the product is sterile.

    Product
    Epi-Shugarcaine Kit Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1409-60
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Reck Injection Due to Sterility Concerns

    Pharm D Solutions is recalling 517 syringes of Reck Injection because the product lacks assurance of sterility. The recall covers lots distributed nationwide.

    Product
    Reck Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1459-50
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Arginine Injections Due to Sterility Concerns

    Pharm D Solutions is recalling Arginine Injections 100 mcg/mL due to a lack of assurance of sterility. The affected lots were distributed nationwide.

    Product
    Arginine Injections 100 mcg/mL, Pharm D Solutions, Houston, Texas NDC 69699-1414-20
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Atropine Solution Due to Sterility Concerns

    Pharm D Solutions is recalling QM-4A Quadmix Atropine 0.4 mg Aqueous Solution because there is a lack of assurance of sterility.

    Product
    QM-4A Quadmix 5 mL 30 PA-2PH-150A-Atropine 0.4 mg Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1342-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Epinephrine Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling 945 syringes of Epinephrine 1 mg/1 mL injectable solution nationwide due to a lack of assurance of sterility.

    Product
    Epinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Trimix T-101 Injection Due to Sterility Concerns

    Pharm D Solutions is recalling Trimix T-101 injection because the product may lack assurance of sterility.

    Product
    Trimix T-101 Alprostadil/Phapaverine/Phentolamine 5.9 mcg/17.65 mg/Phentolamine 0.59 mcg per mL Pharm D Solutions, Houston, Texas --- NDC 69699-1366-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Glutamine Solution Due to Sterility Concerns

    Pharm D Solutions is recalling Glutamine 10 mg/mL Solution because the product lacks assurance of sterility. The recall covers specific lots distributed nationwide.

    Product
    Glutamine 10 mg/mL Solution, Pharm D Solutions, Houston, Texas ---- NDC 69699-1439-59
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Trimix Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling Trimix BM3 Papaverine 30 mg/Phentolamine 1 mg Injectable because the agency could not ensure the product was sterile.

    Product
    Trimix BM3 Papaverine 30 mg/Phentolamine 1 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1354-03
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Bi-Mix Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling 29 vials of Bi-Mix (Papaverine/Phentolamine) injectable and powder nationwide due to a lack of assurance of sterility.

    Product
    Bi-Mix (Papaverine/Phentolamine 150 mg/5 mg) a) Injectable NDC 69699-1760-15; b) (LYO) Powder NDC 69699-1760-15, Pharm D Solutions, Houston, Texas
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Phosphate Buffer Solution Due to Sterility Concerns

    Pharm D Solutions is recalling specific lots of Phosphate Buffer Solution 0.05 m Aqueous Solution because the company cannot assure the product's sterility.

    Product
    Phosphate Buffer Solution 0.05 m Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-0912-20
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Trimix T-106 Due to Sterility Concerns

    Pharm D Solutions is recalling specific lots of Trimix T-106 aqueous solution because the company cannot ensure the product is sterile.

    Product
    Trimix T-106 30PA-1PH-25A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1339-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Trimix Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling specific lots of Trimix QM10 Injectable because the company cannot ensure the product is sterile.

    Product
    Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Tri-Mix Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling 609 vials of Tri-Mix Injectable due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC 69699-1332-05, Pharm D Solutions, Houston, Texas
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Trimix T 101 Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling Trimix T 101 Injectable due to a lack of assurance of sterility. The recall covers a specific lot distributed nationwide.

    Product
    Trimix T 101 Alprostadil/Papverine/Phentolamine 5.9 mcg/17.65 mg/0.59 mcg per mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1336-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Ascorbic Acid Solution Due to Sterility Concerns

    Pharm D Solutions is recalling Ascorbic Acid 500 mg/mL Solution due to a lack of assurance of sterility. The recall affects nationwide distribution.

    Product
    Ascorbic Acid 500 mg/mL Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1502-50
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Testosterone Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling Testosterone in Grapeseed Oil Injectable because the product lacks assurance of sterility. The recall covers multiple vial sizes distributed nationwide.

    Product
    Testosterone in Grapeseed Oil 200 mg/mL, a) 4 mL, b) 5 mL, c) 10 mL and d) 30 mL Injectable, Pharm D Solutions, Houston, Texas NDC 69699-1702-05
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2018-11-07

    Pharm D Solutions Recalls Levocarnitine Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling Levocarnitine 170 mg/mL Injectable because the product lacks assurance of sterility. The recall covers 3,000 milliliters distributed nationwide.

    Product
    Levocarnitine 170 mg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-10
    Category
    Distribution
    0 states